Virtus LifeSci Biotech Clinical Trials ETF Rating $22.87 -0.05 (-0.22%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.94Holdings in BBC have an aggregate rating of Moderate Buy based on 181 analyst ratings issued in the past year covering 24 companies (29.1% of the portfolio).BBC Aggregate Price Target$22.87High Prediction$22.87Average Prediction$22.87Low Prediction$22.87Holdings in BBC have an aggregate price target of $22.87 and a range of $22.87 to $22.87 covering 24 companies (29.1% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.07%CELCCelcuity$54.60+9.3%0.9866 of 5 stars3.00$56.50 3.5%4Gap Up1.47%LQDALiquidia Technologies$27.46-1.9%3.6239 of 5 stars3.00$32.11 16.9%10Positive News1.32%PRTAProthena$8.24-3.7%3.4924 of 5 stars2.33$22.00 167.0%9News CoverageAnalyst ForecastGap Down1.31%TERNTerns Pharmaceuticals$7.07+2.6%3.8014 of 5 stars2.60$15.63 121.0%5News CoveragePositive News1.31%XERSXeris Biopharma$7.90-1.1%3.4124 of 5 stars2.83$7.08 -10.3%6Positive News1.28%COGTCogent Biosciences$12.08-2.3%3.5223 of 5 stars2.82$19.00 57.3%11News CoveragePositive NewsAnalyst Forecast1.23%STOKStoke Therapeutics$19.77+2.4%4.4774 of 5 stars3.22$25.57 29.3%9Positive News1.17%NUVBNuvation Bio$2.92-1.2%2.0522 of 5 stars3.17$7.33 151.6%6News Coverage1.15%UPBUpstream Bio$16.76+0.4%2.3105 of 5 stars3.00$56.50 237.1%4Positive News1.13%SNDXSyndax Pharmaceuticals$16.32+0.4%3.9211 of 5 stars3.00$38.00 132.8%10Positive News1.13%CNTACentessa Pharmaceuticals$16.56-0.5%2.4804 of 5 stars3.00$28.10 69.7%111.08%TNGXTango Therapeutics$6.82-1.2%1.8411 of 5 stars3.00$10.50 54.0%5Insider Trade1.07%ABCLAbCellera Biologics$4.30-1.1%2.2782 of 5 stars3.00$8.00 86.0%6News CoverageGap Up1.07%RNAAvidity Biosciences$48.58+1.6%2.9832 of 5 stars3.06$67.00 37.9%18Positive News1.07%SANASana Biotechnology$3.01-10.7%3.1958 of 5 stars3.00$8.00 165.8%61.06%SVRASavara$3.27-0.6%2.4548 of 5 stars2.83$6.17 88.6%61.06%PHVSPharvaris$22.84-4.0%2.3664 of 5 stars2.83$35.60 55.9%6News Coverage1.06%ARCTArcturus Therapeutics$17.30+0.1%2.8547 of 5 stars3.00$50.57 192.3%81.05%OLMAOlema Pharmaceuticals$5.52-3.8%1.9484 of 5 stars2.67$24.00 334.8%61.04%WVEWAVE Life Sciences$9.93-1.5%4.7744 of 5 stars2.93$20.27 104.1%15Insider Trade1.01%MNMDMind Medicine (MindMed)$9.78-0.7%2.6714 of 5 stars3.22$24.71 152.7%9Positive News1.00%LENZLENZ Therapeutics$38.20+2.2%2.0277 of 5 stars3.17$49.60 29.8%61.00%RAPPRapport Therapeutics$16.80+12.2%1.7878 of 5 stars3.00$29.50 75.6%2Positive NewsGap UpHigh Trading Volume0.99%SIONSionna Therapeutics$25.72+2.3%1.761 of 5 stars3.00$38.50 49.7%3Insider Trade This page (NYSEARCA:BBC) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access